Exposure Therapy for Fear of Falling in Older Adults

December 19, 2013 updated by: Julie Wetherell, University of California, San Diego
This project aims to test the efficacy of an in-home intervention, "Activity, Balance, Learning, and Exposure" (ABLE), which integrates exposure therapy with cognitive restructuring, exercise, and home safety evaluation for older adults with excessive fear of falling. The intervention will be conducted by a licensed physical therapist. A control intervention will be conducted by a health educator. The specific aims of the study are to test the feasibility, acceptability, tolerability, and safety of the ABLE intervention.

Study Overview

Detailed Description

Approximately 7-14% of older adults living independently in the community, including more than 5% of those who have never experienced a fall, experience moderate to severe fear of falling. Fear of falling leads to decreased physical activity, disability, loss of independence, depression, anxiety, reduced social engagement, and poor quality of life. It is also a major independent risk factor for falls.

Interventions targeting fear of falling, typically delivered in groups and incorporating cognitive restructuring, education, and exercise, have been shown to increase fall-related self-efficacy. Avoidance is resistant to treatment, however, and more than one-third of patients enrolled in these interventions drop out. Factors associated with attrition include high levels of fear and avoidance, indicating that the individuals most in need of such programs are those most likely to withdraw prematurely. These data suggest that avoidance should be targeted in treatment, and that interventions should be designed to reach very fearful individuals who are most likely to drop out of traditional fear of falling programs.

Participation in this study will last up to 8 months. Participants will be randomly assigned to receive either the ABLE intervention or an education control condition. The control condition will consist of in-person education about falls to control for the time and attention provided in the ABLE arm.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92103
        • University of California San Diego

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age 65 years old or older.
  2. Severe fear as measured by a brief FES-I score > or = 13.
  3. Low to moderate actual risk of falls as set out in Lamb et al. (2008).
  4. Distress or functional impairment due to fear of falling.
  5. Approval from the patient's primary health care provider.

Exclusion Criteria:

  1. Medical condition that would interfere with the safe conduct of the intervention or compromise study participation.
  2. Bedbound, wheelchair-dependent, paralyzed in the lower extremities, or requiring the assistance of another person to transfer, walk, or perform intervention exercises within the home.
  3. Dementia or cognitive impairment as measured by a score above 10 on the Blessed Orientation Memory Test.
  4. Corrected visual acuity < 20/60.
  5. Current participation in psychotherapy or professional rehabilitation services (PT, OT) or in the process of being referred or evaluated for such services. Patients who develop a need for such services during their participation will complete an assessment prior to commencing the outside therapy but will be allowed to continue in the study.
  6. Active suicidal ideation
  7. Lifetime diagnosis of bipolar I or II disorder or any psychotic disorder.
  8. Alcohol or other substance abuse or dependence within six months.
  9. Psychosocial factors that would compromise study participation (e.g. homelessness, no telephone).
  10. History of osteoporotic fracture.
  11. Experiencing 3 or more falls in the past year.
  12. Body Mass Index of 17.0 or under.
  13. Significant orthostasis, defined as a 20 point or greater difference between seated and standing blood pressure, either systolic or diastolic.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Education about falls
In-person education about falls with a health educator.
In-home, individual sessions with a health educator regarding fall prevention
EXPERIMENTAL: Activity, Balance, Learning, and Exposure
Intervention combining medication review, exercise, home safety evaluation, and exposure therapy.
An in-home intervention that integrates exposure therapy with cognitive restructuring, exercise, and a home safety evaluation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fear of falling
Time Frame: 2 months (primary)
Fear of Falling will be measured using the Falls Efficacy Scale - International (FES-I), a version of the most widely used measure of falls self-efficacy. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point). We will also collect data at 5 months (3 month follow-up) and 8 months (6 month follow-up).
2 months (primary)
Activity avoidance
Time Frame: 2 months (primary)
Activity avoidance will be assessed using a modified version of the Activity Card Sort, a set of photographs of older adults engaged in various activities that is used in rehabilitation settings. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point), 5 months (3 month follow-up), and 8 months (6 month follow-up).
2 months (primary)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity - self-report
Time Frame: 2 months (primary)
Self-reported physical activity will be assessed with the Physical Activities Scale for the Elderly (PASE).
2 months (primary)
Physical activity
Time Frame: 2 months
Accelerometers will also be used to measure physical activity. Patients in the study will wear an Actigraph battery-operated activity monitor worn around the waist to measure physical activity continuously during waking hours. Assessment will occur before and after the intervention.
2 months
Physical Performance
Time Frame: 2 months (primary)
Physical performance will be measured using the Short Physical Performance Battery (SPPB), which includes measured of balance, walking, and lower body strength.
2 months (primary)
Quality of Life
Time Frame: 2 months (primary)
Quality of life will be measured with the Quality of Life Inventory (QOLI).
2 months (primary)
Depressive and Anxiety symptoms
Time Frame: 2 months (primary)
Depressive and anxiety symptoms will be assessed with the Hospital Anxiety and Depression Scale (HADS), a 14-item self-report measure with subscales assessing depressive and anxiety symptoms that does not include somatic items such as fatigue that can be associated with aging or medical conditions rather than psychiatric disorders.
2 months (primary)
Agoraphobic Avoidance
Time Frame: 2 months (primary)
Agoraphobic avoidance will be measured using the 5-item agoraphobia subscale of the Fear Questionaire (FQ).
2 months (primary)
Post Traumatic Stress Disorder Symptoms
Time Frame: 2 months (primary)
Post Traumatic Stress Disorder (PTSD) symptoms will be measured with the 6-item abbreviated form of the PTSD Checklist (PCL).
2 months (primary)
Fear of Falling
Time Frame: 2 months (primary)
Fear of falling will be measured using the Falling Questionaire, a 15-item survey assessing attitudes towards falling.
2 months (primary)
Avoidance
Time Frame: 2 months (primary)
Avoidance of activities will be measured using the Fear of Falling Avoidance-Behavior Questionaire (FFABQ), a 14-item measure to assess avoidance behaviors.
2 months (primary)
Falls
Time Frame: 2 months (primary)
Recorded on fall diaries provided to investigators throughout the 2-month intervention and 6-month follow-up period.
2 months (primary)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Julie Wetherell, PhD, UCSD

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2010

Primary Completion (ACTUAL)

August 1, 2013

Study Completion (ACTUAL)

August 1, 2013

Study Registration Dates

First Submitted

May 29, 2012

First Submitted That Met QC Criteria

May 30, 2012

First Posted (ESTIMATE)

May 31, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

December 23, 2013

Last Update Submitted That Met QC Criteria

December 19, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • R34MH086668 (NIH)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fear of Falling

Clinical Trials on Fall prevention education

3
Subscribe